Post-translational Modification of Protein Biopharmaceuticals
Kurzinformation
inkl. MwSt. Versandinformationen
Artikel zZt. nicht lieferbar
Artikel zZt. nicht lieferbar
Beschreibung
From the leading author in the field, known around the world for his work and his authoritative publications, the contents of this book have been selected so as to reflect their relative importance for biopharmaceuticals. As a result, around half of the book is devoted to protein glycosylation, while the remainder is made up of other modifications, such as carboxylation, hydroxylation, sulfation, amidation and proteolytic processing. A final section addresses the latest trend of engineering the modification pattern to improve a given biopharmceutical, presenting several recent case studies of successful posttranslational engineering. This first authoritative overview of the topic is an indispensable guide for drug developers and drug manufacturers with an interest in protein pharmaceuticals.
Produktdetails
So garantieren wir Dir zu jeder Zeit Premiumqualität.
Über den Autor
Gary Walsh is a senior lecturer in industrial biochemistry at the University of Limerick, Ireland. He combines industrial experience within the pharmaceutical industry with an extensive teaching and academic research background in pharmaceutical biotechno
- Hardcover -
- Erschienen 2009
- Springer-Verlag GmbH
- Hardcover
- 640 Seiten
- Erschienen 2017
- Wiley-VCH
- Hardcover
- 430 Seiten
- Erschienen 2021
- Wiley-VCH
- hardcover
- 400 Seiten
- Erschienen 2022
- Wiley-VCH
- Hardcover
- 704 Seiten
- Erschienen 1993
- Crc Pr Inc
- Taschenbuch
- 344 Seiten
- Erschienen 2000
- Oxford University Press
- Hardcover
- 116 Seiten
- Erschienen 2003
- Springer